SCHEMBL18653252

SCHEMBL18653252

NOCCCCCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15254172 1.00 ODC1 (0.45)
SCHEMBL15254562 1.00 ODC1 (0.45)
SCHEMBL15254439 1.00 ODC1 (0.45)
SCHEMBL15254005 1.00 ODC1 (0.45)
SCHEMBL15254213 1.00 ODC1 (0.45)
SCHEMBL15253912 1.00 ODC1 (0.45)
SCHEMBL15254361 1.00 ODC1 (0.45)
SCHEMBL15254591 1.00 ODC1 (0.45)
SCHEMBL15254169 1.00 ODC1 (0.45)
SCHEMBL2466589 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230323344-A1 POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER ARES CAPITAL CORPORATION, AS AGENT 2023-10-12 US disclosed
EP-4101930-A1 POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION ModernaTX, Inc. (US) 2022-12-14 EP disclosed
EP-3350333-B1 POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION MODERNATX INC (US) 2021-10-27 EP disclosed
US-20190078087-A1 POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER ARES CAPITAL CORPORATION, AS AGENT 2019-03-14 US disclosed
WO-2017049275-A2 POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION MODERNA THERAPEUTICS, INC. (US) 2017-03-23 WO disclosed
WO-2017049286-A1 POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER MODERNA THERAPEUTICS, INC. (US) 2017-03-23 WO disclosed